Medicine Research Studies | Medical News, Treatment Articles


FDA Wants More Data on Viaskin Peanut Allergy Patch

The FDA noted that it could not approve the BLA due to concerns regarding “the impact of patch-site adhesion on efficacy and indicated the need for patch modifications, and subsequently a new human factor study.”
Next post in Medicine